CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise
Read More
Sanofi SA
‘Good value, low risk, high quality’: BofA names top Europe stocks to beat a recession
Bank of America's list of top European picks includes stocks ranging from Mercedes-Benz to GSK, and Shell to LVMH. Source
Read More
Sanofi expects infant RSV shot to roll out before respiratory virus season this fall
Sanofi said it is working with a CDC panel to include Beyfortus on the childhood immunization schedule and the Vaccines
Read More
FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV
FDA approves AstraZeneca, Sanofi shot that protects infants and toddlers against RSV Source link
Read More
FDA advisors recommend AstraZeneca, Sanofi antibody to protect babies from RSV
If the Food and Drug Administration approves nirsevimab, it will be the first medical intervention available in the U.S. that
Read More
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
He was the only executive to do so before a Senate Health Committee hearing that also included the CEOs of
Read More
Senate legislation would cap insulin at $35 per month for people with private insurance
More than 2 million patients with diabetes who take insulin are privately insured, according to the Health and Human Services
Read More
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs
Read More
Novo Nordisk to slash U.S. insulin prices by up to 75%, following move by Eli Lilly
Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following
Read More